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Abstract
To explore how cardiac regeneration and cell turnover adapts to disease, different forms of stress were studied for their
effects on the cardiac progenitor cell markers c-Kit and Isl1, the early cardiomyocyte marker Nkx2.5, and mast cells. Adult
female rats were examined during pregnancy, after myocardial infarction and ischemia-reperfusion injury with/out insulin
like growth factor-1(IGF-1) and hepatocyte growth factor (HGF). Different cardiac sub-domains were analyzed at one and
two weeks post-intervention, both at the mRNA and protein levels. While pregnancy and myocardial infarction up-regulated
Nkx2.5 and c-Kit (adjusted for mast cell activation), ischemia-reperfusion injury induced the strongest up-regulation which
occurred globally throughout the entire heart and not just around the site of injury. This response seems to be partly
mediated by increased endogenous production of IGF-1 and HGF. Contrary to c-Kit, Isl1 was not up-regulated by pregnancy
or myocardial infarction while ischemia-reperfusion injury induced not a global but a focal up-regulation in the outflow tract
and also in the peri-ischemic region, correlating with the up-regulation of endogenous IGF-1. The addition of IGF-1 and HGF
did boost the endogenous expression of IGF and HGF correlating to focal up-regulation of Isl1. c-Kit expression was not
further influenced by the exogenous growth factors. This indicates that there is a spatial mismatch between on one hand c-
Kit and Nkx2.5 expression and on the other hand Isl1 expression. In conclusion, ischemia-reperfusion injury was the
strongest stimulus with both global and focal cardiomyocyte progenitor cell marker up-regulations, correlating to the
endogenous up-regulation of the growth factors IGF-1 and HGF. Also pregnancy induced a general up-regulation of c-Kit
and early Nkx2.5+ cardiomyocytes throughout the heart. Utilization of these pathways could provide new strategies for the
treatment of cardiac disease.
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Introduction
The adult heart is not a terminally differentiated organ but
maintains regenerative capacity through out life [1]. During the
cold war nuclear bomb tests released carbon-14 (
14C) into the
atmosphere, which was then incorporated into the genomic DNA
of proliferating cells. Because of this phenomenon it is now
possible for the first time to determine the age of cardiomyocytes
in the adult heart. If one discounts the polyploidisation of DNA in
cardiomyocytes during childhood [2,3], then there is a turn over of
1% of cardiomyocytes per year at the age of 25 and 0.45% of
cardiomyocytes at the age of 75. This implies that 50% of our
cardiomyocytes have been replaced during our lifetime.
The concept of myocardial regeneration by means of stimulat-
ing or augmenting the endogenous regenerative potential in situ is
an attractive approach. This offers distinct advantages to stem cell
implantation since the problems with engraftment and immune
rejection are avoided. Despite of the recent enthusiasm, several
issues remain unsolved, like which progenitor cells are responsible
for the normal myocardial homeostasis and which stem cells are
up-regulated most during a response to physiological and
pathological stress? Many research groups have reported on
different types of stem cell- like cells from different species. These
include cells with surface expression of molecules like stem cell
antigen-1 (Sca-1) [4,5,6], Abcg2 [7,8,9], c-Kit [10,11,12,13,14,15]
and the transcription factors Tbx 5 and Islet-1 (Isl1) [16,17,18,19].
It is still unclear if progenitor cells which express Sca-1, c-Kit or
Abcg2 all come from the same stem cell and represent different
physiological states or if they are different cell types [20]. Of the
described cells, only the cells expressing c-Kit demonstrate the
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multipotency [10]. Miyamoto and co-workers have isolated and
successfully cultured c-Kit+ cells from adult rat hearts for 40
passages [13]. These cells maintained their stem cell characteristics
and could differentiate into cardiomyocytes, smooth muscle and
endothelial cells. Both side population cells expressing Abcg2 and
some Sca-1+ cells, co-express c-Kit [4,7,8,9], which implies that
these cells are derived from multipotent c-Kit+ cells. Goumans et
al. have presented results where cardiomyocyte progenitor cells
have been isolated from human fetal and adult hearts using
a mouse antibody for Sca-1 [21]. The isolated cardiomyocyte
progenitor cells expressed moderate levels of c-Kit and could
differentiate into cardiomyocytes after stimulation with 59-
azacytidine and TGF-b1.This finding further emphasizes the
concept that c-Kit+ cells can be cardiomyocyte progenitor cells
both in rodents and in man.
Other important cardiovascular progenitors are the Isl1+ cells,
which form the second heart field during organogenesis [16]. In
vivo cell lineage tracing in mouse embryos using the cre-loxP
strategy has confirmed that Isl1+ progenitors contribute to more
than two-thirds of the cells in the embryonic heart [18,22,23]. The
majority of Isl1+ cells in rat embryos are localized to the outflow
tract and differentiate to cardiomyocytes where they express both
troponin T (TnT) and a-smooth muscle actin (a-SMA) [17]. Isl1+
cells have also been localized to the outflow tract of adult pregnant
rat hearts [17], which could imply that they contribute to the
generation of cardiomyocytes during stress.
Dual delivery of insulin like growth factor-1 (IGF-1) and
hepatocyte growth factor (HGF) from affinity-bound biomaterial
has previously shown to reduce apoptosis, induce cardiomyocyte
cell-cycle re-entry and increase the incidence of GATA-4 positive
cell clusters in a rat myocardial infarction model [24].Therefore it
is interesting to study if endogenous IGF-1 and HGF are involved
in the up-regulation of cardiac progenitors due to stress and if local
administration of these growth factors could further potentiate this
effect.
Subsequently there seems to be at least two cardiac progenitor
cells; one which expresses c-Kit, and one which expresses Isl1.
This is the first blinded longitudinal study, which explores the up-
regulation of cardiac progenitor cells during different forms of
physiological and pathological stress like pregnancy, myocardial
infarction, and ischemia-reperfusion injury. We believe that this
study indicates that there exists a cardiogenic c-Kit+ population
and that these progenitor cells together with Isl1+ cells take part in
myocardial regeneration following pathological and physiological
stress.
Materials and Methods
Experimental Design
The study design is shown in Figure 1. All the procedures were
approved (approval ID S68-09 and S175-09) by the Animal Care
Committee of Karolinska University Hospital, Stockholm, Sweden
and conform to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No.85-23, revised 1996). The rats were allowed free access
to water and conventional pellet diet.
In this study we used female adult (11–13 weeks old) Sprague
Dawley rats (Charles River, Germany) which were divided into
five groups; control, pregnancy, myocardial infarction and
Figure 1. Flow chart showing the experimental study design. In figure; RV: Right ventricle, LV: Left ventricle, OFT: Outflow tract, RT-PCR: Real
Time Polymerase Chain Reaction and ICC: Immunocytochemistry.
doi:10.1371/journal.pone.0036804.g001
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rats (n=13) were not subjected to any surgical event. The
pregnant rats (n=10) used were sacrificed on gestational day (GD)
13, since we have previously shown presence of Isl1+ cells in the
outflow tract at this time of pregnancy [17]. The rats from the
myocardial infarction group (MI, n=15), ischemia-reperfusion
groups (IR) without (IR, n=17) or with (IR+GF, n=16) the
growth factors HGF, IGF-1, were euthanized at the two time
points; 1 week and 2 weeks. At the time of harvest, the hearts were
divided into the different regions; outflow tract (OFT, defined as
the outflow tract of the right ventricle), right ventricle (RV), left
ventricle (LV), area of peri-infarct and peri-ischemia. Subsequent
analysis was performed by Real Time Polymerase Chain Reaction
(RT-PCR), Western blot, and immunocytochemistry (ICC), in
a blinded manner.
Anesthesia and Postoperative Care
The rats that underwent myocardial infarction or ischemia-
reperfusion injury were generally anesthetized with a subcutaneous
injection of Midazolam (Dormicum, 5 mg/kg) (Algol Pharma AB,
Germany), Medetomidin hydrochloride (Domitor vet, 0.1 mg/kg)
(Orion Corp., Espoo, Finland), Fentanyl (0.3 mg/kg) (B.Braun
Medical AG, Seesatz, Switzerland) and subsequently endotrache-
ally intubated. Positive-pressure ventilation was kept at a rate of
100 cycles per minute with a tidal volume of 4–5 ml with room air
using a ventilator (7025 Rodent ventilator, UGO BASILE S.R.L,
Italy).
The anesthesia was reversed by an intramuscular injection of
Flumazenil (Lanexat, 0.1 mg/kg) (Hameln Pharma, Germany)
and Tipamezol hydrochloride (Antisedan vet 5 mg/kg) (Orion
Corp., Espoo, Finland). Postoperative analgesia was maintained by
administrating Buprenorphin hydrochloride (Temgesic,
0.004 mg/kg/twice per day for 3 days) (Schering-Plough Corp.,
Belgium). Rats that showed signs of malfunction were excluded
from the study.
Induction of Myocardial Infarction and Ischemia-
reperfusion Injury
In the myocardial infarction and ischemia-reperfusion groups,
the hearts were exposed through a left lateral thoracotomy. In the
myocardial infarction group the left anterior descending artery
(LAD) was permanently ligated and infarction induction was
confirmed by color change and dyskinesia of the antero-lateral
wall of the left ventricle. In the ischemia-reperfusion groups, the
LAD was temporary ligated for 5 minutes. In the (IR+ GF) group
this was followed by an intramyocardial injection of rrIGF-1(8 mg)
and rhHGF (2 mg) (4326RG and 294HG/CF, R & D systems,
Minneapolis, USA) dissolved in 10% rat serum in PBS and in the
IR-group by an intramyocardial injection of corresponding
volume of 10% rat serum.
Sample Preparation and RNA Extraction
The hearts were harvested through a left thoracotomy. The
hearts were kept cold on dry-ice and subsequently divided into the
different subdomains; OFT, RV, LV and when applicable the area
of peri-ischemia and peri-infarct. All the heart samples were snap-
frozen in liquid nitrogen and kept in minus 70uC until RNA
extraction. Total RNA was extracted from the heart samples
according to the QuickGene RNA tissue assay (RT-S2, Science
Figure 2. Quantitative RT-PCR showing the time-dependent distribution of c-Kit mRNA in the different groups. The c-Kit mRNA
expression in the different groups is related to the expression of GAPDH. Fig A shows the mean of the whole heart c-Kit mRNA expression in each
group. In fig B, the distribution of the c-Kit mRNA between each region at 2 weeks is demonstrated. Number of animals is 7–10 per group (see flow
chart in Fig 1). In figure; MI: myocardial Infarction; IR: ischemia-reperfusion; IR+GF: ischemia-reperfusion+ growth factors. RV: Right ventricle, LV: Left
ventricle, OFT: Outflow tract and Peri-INF/Ischemia: Peri-infarction and Ischemia region respectively. Data is presented as mean 6 SD. *P,0.05 vs.
Control group, ** P,0.001 vs. Control group, ***P,0.05 vs. pregnancy group, ****P,0.05 vs. MI (2 weeks) group and { P,0.05 1 week vs. 2 weeks. In
fig B, each region is related to corresponding region of the control, pregnancy, myocardial infarction and ischemia-reperfusion w/o growth factors.
doi:10.1371/journal.pone.0036804.g002
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810/QG-800Mini80 RNA isolation system. An average of 15–
30 mg heart tissue per each sample underwent a homogenization
process in a homogenization tube containing lysis buffer and
0.5 mm zirconium oxide using the Bullet Blender Homogenizer
TM (Next Advance Inc., USA). The eluted samples were
concentrated to an average of 200 ng RNA/ml using the speed
vacuum system (Max Dry Lyo machine).
The RNA concentrations and purities (A260/280) were
measured in a NanoDrop spectrophotometerH (ND-1000) (Nano-
drop technologies, Wilmington, DE, USA). The RNA quality was
further evaluated by 1% agarose-gel electrophoresis. These
measurements were performed before and after the concentration
step to assure proper selection of the high quality samples.
Quantitative Real-Time Polymerase Chain Reaction (RT-
PCR)
Two micrograms of total RNA was reverse transcribed by
Superscript reverse transcriptase (Life Technologies, Stockholm,
Sweden) using random hexamer primers (Roche Diagnostics
GmbH, Mannheim, Germany) in a total volume of 20 ml.
Real-time PCR was used to measure mRNA expression on
a 7500 Fast real-time PCR system (Applied Biosystems Inc., Foster
City, CA, USA). Primers and probes were supplied as a TaqManH
Reagents kit (Applied Biosystems), Isl1 Rn00569203 m1, Kit Rn
00573942 m1, Nkx 2.5 Rn 00586428 m1, IGF-1 Rn
00710306 m1, HGF Rn 00566673 m1, Gapdh Rn 00000016
m1. GAPDH was used as an endogenous control to correct for
potential variation in cDNA loading.
All PCR reactions were performed in 96-well MicroAmp
Optical plates (Applied Biosystems). cDNA was diluted 1:5.
Amplification reagents (10 ml) contained 1 ml sample for c-Kit
and Nkx 2.5 and 5 ml for Isl1 in TaqMan Universal PCR
Mastermix.
All samples were run in duplicates. Each RT-PCR cycle
consisted of: Initial activation stage at 95uC (10 min), then the
denaturation stage at 95uC (15 sec) and the annealing stage at
60uC (60 sec) cycled 40 times.
The comparative DCt method was used to calculate the relative
gene expression to GAPDH for the genes analyzed [25].
Immunocytochemistry
The whole hearts were mechanically minced into small pieces,
treated with collagenase type II solution (CLS-2, Worthington,
Biochemical Corporation, USA) to receive single cell suspensions
for subsequent cytospin. To identify mast cells in the cytospin
Figure 3. Quantitative RT-PCR showing the time-dependent distribution of the Nkx2.5 early cardiomyocyte progenitor in the
different groups. The Nkx2.5 mRNA expression in the different groups was related to the expression of GAPDH. Fig A shows the mean of the whole
heart Nkx2.5 mRNA expression in each group. In fig B, the distribution of Nkx2.5 mRNA between each region of the myocardial infarction group at
1 weekis demonstrated. In fig C, the Nkx2.5 mRNAdistributionbetweeneach regionis demonstrated at 2 weeks.Numberof animalsis 7–10 pergroup
(seeflowchartinFig1).Infigure;MI:myocardialinfarction;IR:ischemia-reperfusion;IR+GF:ischemia-reperfusion+growthfactors.RV:Rightventricle,LV:
Left ventricle, OFT: Outflow tract and Peri-INF/Ischemia: Peri-infarction and Ischemia region respectively. Data is presented as mean 6 SD. *P,0.05 vs.
Controlgroup,**P,0.001vs.Controlgroup,***P,0.05vs.pregnancygroup,****P,0.05vs.MI(2weeks)groupand{P,0.05,1weekvs.2weeksand{{
P,0.05 vs. MI (1 week) group. In fig B and C the mRNA expression of each region is related to the corresponding region of the control group.
doi:10.1371/journal.pone.0036804.g003
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was fixed in 4% formalin, washed in dH2O and immersed in 1%
Toluidineblue (Toluidineblue, 1B-481, Waldeck, Germany) in
70% ethanol, pH 1.5 for 10 seconds and visualized under light
microscope. Mast cells stain red-purple (metachromatic staining)
and the background stain blue (orthochromatic staining). Semi-
quantitative analyses to determine the relative number of mast
cells to the total number of cells in the cytospins were performed.
Four whole heart cytospins from two rats per group were counted
in the light microscope.
Immunofluorescence Staining
The adult rat hearts from each group were freeze-sectioned into
5-mm-thick sections, except for the Isl1 cell detection where whole
heart cytospins were prepared. The frozen sections or cytospined
cells were fixed in 4% formaldehyde, ice-cold methanol, or
acetone, blocked with serum followed by incubation with the
primary antibodies; mouse anti-rat supernatant Isl1 (1:800, DSH
39.4 D5-s; Columbia University, USA), human NKx2.5 mono-
clonal mouse IgG1 antibody (1:75, R&D MAB2444, clone
259416, Minneapolis, MN) and mouse SCF R/c-Kit goat
polyclonal IgG antibody (1:40, R&D, AF1356). In the next step,
the sections or cells were incubated with the fluorescence-labeled
secondary antibodies; AlexaFluor 488 for c-Kit and Isl1 and
AlexaFluor 546 for Nkx2.5 (Invitrogen, Carlsbad, CA) and
visualized in the fluorescence microscope (Olympus BX60;
Olympus Optical Co. Ltd., Tokyo, Japan) using diamidino-2-
phenylindole (DAPI) in the mounting medium. As positive controls
we used human fetal hearts for Nkx2.5; human fetal hearts, rat
embryos, and an insulin cell line (INS 1E) for Isl1 and for c-Kit we
used adult rat spleen, adult rat kidney and rat embryos. As
negative controls, the primary antibody was omitted and staining
was only performed with the secondary antibody. To test for
autofluorescence, staining was performed without both primary
and secondary antibodies.
Semi-quantitative analyses were performed to determine the
relative number of cells expressing the different markers (Nkx2.5,
c-Kit and Isl1) in relation to the total number of cells per each
field. Slides (n=3–4 from each heart, 2 hearts from each group)
were counted at 40 x magnification in the fluorescence micro-
scope. Due to the scarcity of detected Isl1 positive cells, semi-
quantitative analysis was performed on cells expressing Nkx2.5 as
well as c-Kit.
Western Blot
Cells from cytospins (3–4 slides/group) were directly lysed with
100 mL Laemmli sample buffer and proteins were separated on
gradient 4–12% Bis-Tris NuPAGE gels. Proteins were transferred
to nitrocellulose membranes using Iblot (Invitrogen, USA) and
total protein loadings were assessed with Ponceau S solution
(P7170-1L, Sigma Life Science, Sweden). Membranes were
blocked with non-fat 5% dry milk for one hour in room
temperature (RT) and were incubated over-night (4uC) with
mouse monoclonal c-Kit (MS-289-P1, Thermo scientific, UK)
1:1000, mouse anti rat supernatant Isl1 (DSH 39.4 D5-s,
Colombia University, USA) 1:500 and polyclonal goat Nkx2.5
(SAB2501264, Sigma-Aldrich, Sweden) 1:1000. GAPDH was used
as a loading control; mouse monoclonal GAPDH (ab8245,
Abcam, UK) 1:5000. Membranes were washed four times with
PBST and incubated with the secondary antibodies (Li-COR goat
Figure 4. Quantitative RT-PCR showing the time-dependent distribution of Isl1 mRNA in the different groups. The Isl1 mRNA
expression in the different groups was related to the expression of GAPDH. Fig A shows the mean of the whole heart Isl1 mRNA expression in each
group. In fig B, the distribution of Isl1 mRNA between each region is demonstrated at 2 weeks. Number of animals is 7–10 per group (see flow chart in
Fig 1). In figure; MI: myocardial infarction; IR: ischemia-reperfusion; IR+GF: ischemia-reperfusion+ growth factors. RV: Right ventricle, LV: Left ventricle,
OFT: Outflow tract and Peri-INF/Ischemia: Peri-infarction and Ischemia region respectively. Data is presented as mean6 SD. *P,0.05 vs. Control
group, ***P,0.05 vs. pregnancy group, ****P,0.05 vs. MI (2 weeks) group and { P,0.05, 1 week vs. 2 weeks. In fig. B the mRNA expression of each
region is related to the corresponding region of the control group.
doi:10.1371/journal.pone.0036804.g004
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32214) 1:20 000, for one hour in RT. Membranes were washed
three times with PBST then twice with PBS and finally scanned
using Li-COR scanner. Experiments were run in triplicates.
Statistics
All data are expressed as mean 6 standard deviation. Non-
parametric (Mann-Whitney U) test was employed to calculate the
statistical significance between two independent groups. Statistical
correlations were analyzed with the Pearson correlation test.
A P,0.05 and P,0.001 were considered to be statistically
significant and highly significant respectively. Statistical analysis
was performed with the SPSS software version 17.0.
Results
The Effect of Ischemia-reperfusion Injury, Myocardial
Infarction and Pregnancy on the Expression of c-Kit, Isl1
and Nkx2.5
In this study we have chosen to utilize c-Kit and Isl1 as markers
for cardiomyocyte progenitor cells and Nkx2.5 [27] as a marker to
detect early differentiation into cardiomyocytes. Based on the
quantitative RNA analysis from the different groups, ischemia-
reperfusion injury (IR and IR+GF) induced a stronger up-
regulation of c-Kit, Isl1 and Nkx2.5 versus the control group
than both myocardial infarction and pregnancy (Fig 2A, 3A, 4A).
In the ischemia-reperfusion groups, the up-regulation of c-Kit, Isl1
and Nkx2.5 was mainly seen after 2 weeks (Fig. 2A, 3A, 4A).
After myocardial infarction (MI), there is an inverted trend
between c-Kit and Nkx2.5 expression. The Nkx2.5 expression
reached its maximum already at one week (Fig 3A), while for c-Kit
this occurred at two weeks (Fig 2A).
Ischemia-reperfusion injury induced a similar up-regulation of
c-Kit in all of the studied sub-domains; right ventricle, left
ventricle, outflow tract area and area of peri-ischemia (Fig 2B). In
myocardial infarction there was a general up-regulation of c-Kit,
with a more robust c-Kit response in the remote left ventricle and
the area of peri-infarction compared to the corresponding left
ventricle in the control group (Fig 2B).
Thereisahighlysignificantcorrelationbetweentheup-regulation
ofc-Kit,whichoccurredtwoweeksafterischemia-reperfusioninjury
and the up-regulation of the early cardiomyocyte marker Nkx2.5
(P,0.001,r=0.524)(Fig3Aand5A).Thisup-regulationofNkx2.5,
which was induced by ischemia-reperfusion injury, took place
globally and in the same cardiac sub-domains as the increased
expression of c-Kit (Fig 3C). Unexpectedly, there was an inverted
temporal response between c-Kit and Nkx2.5 expression following
myocardialinfarction,wherec-Kitexpressionincreasedfromweek1
toweek2whileNkx2.5expressionreacheditsmaximallevelalready
after one week (Fig 2A, 3B). The reaction was not focal but global
throughout the myocardium, with no differences between the
different sub-domains ofthe heart (Fig3B).
Initially the expression of Isl1 was very low, in the order of
about 1/500 of the mRNA expressions of c-Kit and Nkx2.5. In
contrary to the expression of these progenitor markers, the Isl1 was
focally expressed, primarily localized to the outflow tract and the
right ventricle (see control group Fig 4A, B). Ischemia-reperfusion
injury induced a robust up-regulation of Isl1 expression compared
Figure 5. Correlations between cardiomyocyte progenitors and endogenous IGF-1/HGF mRNA expressions in the different groups.
The scatter plots on logged data in Fig 5A, B and E reveal that Nkx2.5 is positively correlated with c-Kit, Isl1 and HGF expression. c-Kit is also positively
correlated to IGF-1 expression (Fig 5C) and there is a borderline relationship to HGF expression (Fig 5D). As shown in fig F, Isl1 is positively correlated
with IGF-1 expression. In figure; R=Pearson correlation coefficient.
doi:10.1371/journal.pone.0036804.g005
IR Injury Up-Regulates Cardiac Progenitors
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36804to myocardial infarction (Fig 4A). The up-regulation induced by
ischemia-reperfusion injury and myocardial infarction was mainly
in other sub-domains than the up-regulation of c-Kit. In contrast
to the c-Kit response, the up-regulation of Isl1 as a response to
ischemia-reperfusion and myocardial infarction was mainly
located in the outflow tract area, but also in the remote areas of
the left ventricle and peri-ischemic regions (Fig 4B). Up-regulation
of Isl1 correlated also to the Nkx2.5 response (P=0.01, r=0.213)
(Fig 5B), even if this correlation was weaker than for c-Kit.
We also wanted to study if dual delivery of the growth factors
HGF and IGF-1 could boost the effects induced by ischemia-
reperfusion injury. IGF-1 and HGF did not affect the expression of
c-Kit (Fig 2A, B). Interestingly, there was a trend where the
expression of Nkx2.5 increased after treatment with the growth
factors, primarily in the remote left ventricle and peri-ischemic
regions (Fig 3C).The expression of Isl1 was also stimulated by IGF-
1 and HGF, especially in the outflow tract area. Even if the
expression of Isl1 in the peri-ischemic region was lower than that
seen in the outflow tract, following ischemia-reperfusion injury
with the addition of growth factors there was a substantial up-
regulation of Isl1 in this area compared to the control group
(Fig 4A, B).
Pregnancy, also to a certain degree, stimulated the up-
regulation of c-Kit and Nkx2.5 (Fig 2A, 3A) to a level equivalent
to the stimulation seen after myocardial infarction. The response
was similar in all regions of the heart (Fig 2B, 3C). However,
pregnancy did not seem to affect the expression of Isl1 (Fig 4A).
Endogenous IGF-1 and HGF are Involved in the Up-
regulation of Cardiac Progenitors
The endogenous up-regulation of IGF-1 and HGF followed the
same pattern as for cardiac progenitors in the ischemia-reperfusion
groups w/o growth factors at two weeks (Fig 6A, C respectively).
Interestingly, the sub-domain analysis revealed a preferential up-
regulation of IGF-1 at the site of injury (P,0.05) (Fig 6B), while
the HGF expression correlated with a more diffuse up-regulation
in the peri-ischemic region as well as in the right ventricle (P,0.05
and P,0.001 respectively) (Fig 6D).
In the myocardial infarction group there was a divergent
reactivity, with marginal up-regulation of IGF-1 (P=0.06) (Fig 6A),
especially at the site of injury (Fig 6C) and significant (P,0.05)
down-regulation of endogenous HGF (Fig 6C and D).
The observed up-regulations of cardiac progenitors in the
pregnancy group did not seem to be mediated by IGF-1 or HGF
(Fig 6A, B).
To further investigate the role of IGF-1/HGF in the up-
regulation of the different cardiac progenitor markers, correlation
analyses were performed. According to these results, c-Kit mRNA
expression was shown to correlate to the IGF-1/HGF expression
(P=0.003, r=0.235, and P=0.066, r=0.160, respectively)
(Fig 5C, D).
Furthermore, Nkx2.5 up-regulation was positively (P=0.004,
r=0.245) correlated to endogenous HGF expression but not IGF-
1 (Fig 5E), while Isl1 expression was related to (P=0.005,
r=0.241) endogenous IGF-1 expression (Fig 5F).
Figure 6. Quantitative RT-PCR showing the endogenous expression of IGF-1 and HGF mRNA at two weeks in the different groups.
The IGF-1 and HGF mRNA expression is related to the expression of GAPDH. Fig A and C, show the mean whole heart expression of IGF-1 and HGF in
the different groups, while in fig B and D the growth factor expression in each sub-domain is demonstrated. Number of animals is 7–10 per group
(see flow chart in Fig 1). In figure; MI: myocardial Infarction; IR: ischemia-reperfusion; IR+GF: ischemia-reperfusion+ growth factors. RV: Right ventricle,
LV: Left ventricle, OFT: Outflow tract and INF: Peri-infarction and Ischemia region respectively. Data is presented as mean6 SD. *P,0.05 and
**P,0.001 vs. Control group. In fig. C and D the mRNA expression of each region is related to the corresponding region of the control group.
doi:10.1371/journal.pone.0036804.g006
IR Injury Up-Regulates Cardiac Progenitors
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36804Correlation Between mRNA and Protein Expression
The mRNA expression patterns of c-Kit, Isl1 and Nkx2.5 were
confirmed at the protein level at two weeks using both
immunohistochemistry (IHC) and Western blot analyses. The
protein expression levels determined by Western blot correlated
consistently with the mRNA data, with the highest protein
expression of c-Kit, Isl1 and Nkx2.5 in the ischemia-reperfusion
injury groups (IR and IR+GF) (Fig 7D). The protein analysis in
the pregnancy group was not reliable due to inter-individual
variation of protein level differences. These variations might be
due to post-translational modifications (data not shown).
Blinded semi-quantitative IHC analyses of cells expressing c-Kit
and Nkx2.5 were performed two weeks post-intervention. As
demonstrated in figure 8A and B, the cellular protein expression of
both Nkx2.5 and c-Kit follow the same pattern as previously
shown both in Western blot and at the mRNA level, where the
highest up-regulation was observed in the ischemia-reperfusion
injury groups (IR and IR+GF).
In consistency with the low mRNA expression of Isl1 in the
different groups, Isl1+ cells were extremely difficult to find in IHC
sections of the hearts. In order to circumvent this problem, whole
heart cytospins were performed where few Isl1+ cells could be
identified in the different groups (Fig 8C). No reliable semi-
quantitative analysis could be performed on the cytospinned
material.
Semi-quantitative Analysis of Mast Cell Expression
Mast cells were detected by Toluidine staining on whole heart
cytospins at two weeks post-intervention. As shown in figure 7A
and B, the positive mast cells stained red-purple and were easy to
detect. The semi-quantitative analysis of mast cells, revealed
a mismatch between the previously shown up-regulation of c-Kit
(Fig 2A) and mast cells (Fig 7C). While pregnancy up-regulated c-
Kit, mast cells were down-regulated. In the ischemia-reperfusion
injury groups (IR and IR+GF) up-regulation of c-Kit (Fig 2A) was
similar with and without growth factors, while addition of growth
factors caused a much higher mast cell expression.
Discussion
This is the first prospective and randomized study, which
examines the time-dependent and spatial up-regulation of the best
characterized cardiomyocyte progenitor markers c-Kit and Isl1, as
well as the early cardiomyocyte marker Nkx2.5, during experi-
mental pathological and physiological stress stimuli in adult rat
hearts. Our study demonstrates global and focal up-regulations of
c-Kit and Isl1, respectively, as well as Nkx2.5, after ischemia-
Figure 7. Mast cell distribution and Western blot analysis. Fig A-C: Two weeks after the intervention, mast cells were detected in whole heart
cytospins from the different groups using toluidineblue staining. As seen in fig A and B, it is easy to detect the mast cells as red-purple cells. Fig C
shows a semi-quantitative analysis of the distribution of mast cells among the different groups. Four whole heart cytospins from two rats per group
were counted in the light microscope. Data is presented as mean6 SD. *P,0.05 vs. Control group and **P,0.05 vs. MI (2 weeks) group. Fig D: The
protein expression for c-Kit, Isl1 and Nkx2.5 is related to the GAPDH expression in each group at 2 weeks. The Isl1 protein expression showed a band
at 39 kDa and another band was consistently observed at 80 kDa. Experiments were run in triplicates (n=2 per group). In figure; MI: myocardial
infarction; IR: ischemia-reperfusion; IR+GF: ischemia-reperfusion+ growth factors. Bars in panel (A)=25 mm and in panel (B)=50 mm.
doi:10.1371/journal.pone.0036804.g007
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pregnancy. Our findings are based on mRNA as well as protein
analyses where both immunohistochemistry and Western blot
analyses were performed on tissue specimens from the different
regions of the heart. By using this strategy, the expressions of Isl1,
c-Kit and Nkx2.5 were verified using three independent methods
which strengthen our conclusions.
Ischemia-reperfusion injury induces the strongest up-regula-
tion of c-Kit and Nkx2.5 expression, which occurs two weeks
after the ischemic event and is found throughout the entire
heart. There is also a spatial mismatch on one hand of c-Kit
and Nkx2.5 and on the other Isl1 expression. Both c-Kit and
Nkx2.5 are globally up-regulated, while the Isl1 up-regulation is
localized to the outflow tract, where these cells previously have
been demonstrated to reside in the rat and human embryonic
hearts [17,28].
The origin and phenotype of the c-Kit+ cells in the adult heart is
still under debate. All c-Kit+ cells are not stem cells since c-Kit can
also be expressed on both mast cells, residing in the myocardium
[29] and on other hematopoietic cells [30,31,32,33].
During myocardial ischemia cardiac mast cells play a pivotal
role in the initiation of the inflammatory response by releasing
pro-inflammatory mediators, which trigger a cytokine cascade
[29,34]. If c-Kit expression was solely due to mast cell
accumulation and activation, the c-Kit expression would be
correlated to changes in mast cell expression, which was not the
Figure 8. Immunohistochemical analysis of Nkx2.5, c-Kit and Isl1 cardiac progenitors. Section A: The distribution of Nkx2.5+ cells in the
myocardium of the different groups together with semi-quantitative analysis. Figures (a-f) represent: 9.5 weeks human fetal heart as a positive control
(a), followed by left ventricular regions from the; control (b), pregnancy (c), myocardial infarction (d), ischemia-reperfusion (e) and ischemia-
reperfusion+growth factors (f) groups, respectively. The delineated areas in figure b-f represent a higher magnification of that region. Bars in panel (a-
f)=100 mm. Figure (g) demonstrates the relative number of Nkx2.5+ cells in relation to the total number of cells in the different groups. Data is
presented as mean6 SD. *P,0.05. Section B: Representative stainings of c-Kit+cells in: adult rat kidney as positive control (a), followed by the left
ventricular regions from the ischemia-reperfusion+growth factors (b, d) and myocardial infarction groups (e). The delineated area in figure (b) is
magnified (100 x) in figure (c). In figures (b-e), red arrows indicate c-Kit+ cells. Bars in figures (a, b)=100 mm and in figures (c-e)=50 mm. Figure (f)
demonstrates the percentage of c-Kit+cells in relation to the total number of cells in the different groups. Data is presented as mean 6 SD. *P,0.05
and **P,0.001. Section C. Representative stainings of Isl1+ cells in whole heart cytospins from (c) pregnancy, (d) myocardial infarction, (e) ischemia-
reperfusion and (f) ischemia-reperfusion+growth factors groups. Figures (a) and (b) represent the positive controls; whole rat embryo ED13 and
insulin cell line-1E respectively. Delineated areas in figure c, d, e and f represent a higher magnification of that region. Bars in figures (a–f)=100mm. In
figure; ED: embryonic day; MI: myocardial infarction; IR: ischemia-reperfusion; IR+GF: ischemia-reperfusion+growth factors.
doi:10.1371/journal.pone.0036804.g008
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demonstrated that there are small clusters of c-Kit+ cells in the
interstitium between mature cardiomyocytes in rat hearts [10].
Furthermore, c-Kit+ cells have also been isolated from human
hearts, and upon transplantation into infarcted myocardium of
immunodeficient rats, they generated a chimeric heart, with new
population of cardiomyocytes and vasculature [10,35]. In keeping
with Beltrami and associates we found that ischemia-reperfusion
injury also seems to stimulate such a pool of ‘‘cardiogenic’’ c-Kit+
cells that give rise to early cardiomyocytes. Besides c-Kit, such cells
also were reported to express the early cardiomyocyte marker
Nkx2.5, a marker that is not expressed by mast cells [10]. How
these cells get activated during ischemia-reperfusion is not known,
but it might be related to the significantly increased endogenous
production of both IGF-1 and HGF as seen in our study.
Exogenous addition of IGF-1 and HGF could further boost the
endogenous expression of these growth factors and further
stimulate the expression of Nkx2.5, primarily in the remote left
ventricle and peri-ischemic regions. These growth factors which
are known to stimulate tissue regeneration [36,37,38,39], might
mediate up-regulation of stem cell factor (SCF), which has
previously been shown to both stimulate proliferation and homing
of c-Kit+ cells [10,40]. Such mechanisms might explain the up-
regulation of ‘‘cardiogenic’’ c-Kit+ cells during ischemia-reperfu-
sion injury. This hypothesis is further supported by a recent study
by Ellison and coworkers, where intra-coronary delivery of IGF-1/
HGF significantly increased c-Kit+/Nkx2.5+ cardiac progenitor
cells in the infarct and border regions in a pig ischemia model [41].
After myocardial infarction and compared to ischemia-reperfu-
sion injury, there was a significantly lower accumulation of c-Kit+
cells in the heart, consistent with the lower expression of
endogenous IGF-1 and HGF in the myocardial infarction group.
It has been shown in other studies that myocardial infarction
induces homing and proliferation of c-Kit+ cells to the border of
the infarction area [10,42], but following permanent coronary
occlusion, such a homing effect may according to our results be
less robust than that seen after ischemia-reperfusion injury.
The transcription factor Isl1 is expressed in the adult heart in
the outflow tract [17] as confirmed in this study. Isl1 expression is
stimulated only in the group exposed to ischemia-reperfusion
injury and foremost after the addition of HGF and IGF-1. Isl1 is
up-regulated primarily in the outflow tract but also in the left
ventricle and the peri-ischemic region. Since the baseline
expression is low it is unclear to what degree Isl1+ cells are
contributing to the regeneration of new cardiomyocytes.
During pregnancy there is a general up-regulation of c-Kit and
Nkx2.5, but not Isl1. This can be interpreted as the hormonal
response to pregnancy stimulates cardiac stem cells and the
generation of new cardiomyocytes, a phenomenon, which has not
been described earlier. Previous studies have only implied that
during pregnancy the heart adapts to an increased workload by left
ventricle hypertrophy [43,44]. According to our data, there also
seems to be hyperplasia involved, through the up-regulation of
cardiac progenitors. To some extent these c-Kit+ and Nkx2.5+
cells might originate from the fetus. This has been shown to be the
case when pregnant mice are exposed to cardiac injury, where
fetal cells home into the injured heart forming endothelial cells,
smooth muscle cells and cardiomyocytes [45]. If these fetal cells
will persist in the maternal tissue as microchimera to protect the
maternal heart from cardiac injury even in the future needs to be
explored.
In conclusion, ischemia-reperfusion injury is the strongest
stimulus for activation of endogenous cardiomyocyte regeneration,
correlating to the endogenous up-regulation of IGF-1 and HGF.
These substances may become utilized to augment the endogenous
regenerative capacity seen in patients with ischemic heart failure
and thereby circumvent the need for stem cell transplantation.
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